Skip to content
Dosage GuideResearch Reference

Pramlintide Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for Pramlintide. All information is for educational purposes only.

Quick Answer

Pramlintide is typically initiated at low doses and titrated upwards based on tolerability. In type 1 diabetes, starting dose is usually 15 mcg, while in type 2 diabetes, it's 60 mcg, both injected subcutaneously immediately prior to meals. The maximum recommended dose is 60 mcg for type 1 and 120 mcg for type 2, but many find optimal control at lower doses.

→ Pramlintide Benefits→ Pramlintide Side Effects→ Full Pramlintide Profile
Table of Contents

Standard Dosage Range

Research dosing range: 15–60 mcg (Type 1 DM); 60–120 mcg (Type 2 DM)

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Type 1 Diabetes (Adjunct to Insulin)

15–60 mcgImmediately before major meals (up to 3× daily)
Duration

Ongoing (as prescribed)

Start at 15 mcg and titrate upwards in 15 mcg increments if tolerated. Reduce prandial insulin by 50% initially to mitigate hypoglycemia risk. Administer via subcutaneous injection.

Type 2 Diabetes (Adjunct to Insulin or Oral Agents)

60–120 mcgImmediately before major meals (up to 3× daily)
Duration

Ongoing (as prescribed)

Start at 60 mcg and titrate upwards in 60 mcg increments if tolerated. Reduce prandial insulin or sulfonylurea dose as appropriate. Monitor glucose closely.

Weight Loss (Off-Label, with Medical Supervision)

30-120 mcg1-3x daily before meals
Duration

Varies, typically short-term (e.g., 8-12 weeks)

Use with caution and close medical monitoring, especially in patients without diabetes, due to potential for hypoglycemia and gastrointestinal side effects. Dosage to be determined by licensed medical practitioner.

Timing & Frequency

Pramlintide is administered via subcutaneous injection immediately prior to major meals. Do not mix with insulin in the same syringe. Inject at least 2 inches away from insulin injection site.

Cycle Guidance

Pramlintide is typically used chronically as part of diabetes management, under physician supervision. Short-term cycling may be considered for off-label weight loss, but the duration should be determined by a healthcare professional.

Reconstitution Reference

Quick reference for reconstituting Pramlintide. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeSupplied as a pre-filled pen
BAC Water VolumeN/A - Pre-filled pen
Concentration & DrawConcentration varies depending on pen type (typically 1000 mcg/mL)
StorageStore refrigerated at 2–8°C. Do not freeze. Protect from light.
StabilityDiscard pen 30 days after first use, even if some pramlintide remains.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What happens if I miss a dose of pramlintide?
If you miss a dose, skip it and take your next dose before your next major meal. Do not double your dose to make up for a missed dose.
Can I mix pramlintide with insulin?
No, pramlintide should not be mixed with insulin in the same syringe. Administer as separate injections.
What should I do if I experience nausea?
Nausea is a common side effect, especially when starting pramlintide. It often resolves over time with continued use. Try eating smaller meals and titrating the dose slowly. Consult your doctor if nausea is severe or persistent.
How do I store my pramlintide pen?
Store your pramlintide pen in the refrigerator (2–8°C). Do not freeze. Keep it protected from light. Discard the pen 30 days after first use, even if it still contains medication.
How does pramlintide work?
Pramlintide mimics the effects of amylin, a natural hormone. It slows gastric emptying, suppresses glucagon secretion, and promotes satiety, leading to improved blood sugar control and potentially weight loss.

Last updated: 2026-02-19